Journey Medical Corp (DERM) income statement
DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3043% below fair value
$3.30−0.25 (-7.04%)
Close on Nov 20, 2026Market cap $93.14MP/E –Yield –
Journey Medical Corp financial ratios
See a number that looks wrong?